SoftOx Solutions ASFRA:6FV 27 EBIT per Share is €0.00 as of Dec. 2025. GuruFocus rates FRA:6FV with a GF Score™ of 27/100. Among 1,173 Biotechnology companies, SoftOx Solutions AS ranks better than 98.21% on this metric.
SoftOx Solutions AS's EBIT per Share for the
three
months ended in Dec. 2025 was €0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00.
During the past 3 years, the average EBIT per Share Growth Rate was 87.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 71.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for SoftOx Solutions AS's EBIT per Share or its related term are showing as below:
FRA:6FV'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -46.1 Med: 8 Max: 87
Current: 87
During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of SoftOx Solutions AS was 87.00% per year. The lowest was -46.10% per year. And the median was 8.00% per year.
FRA:6FV's 3-Year EBIT Growth Rate is ranked better than 98.21% of 1173
companies
in the Biotechnology industry
Industry Median: 15.4
vs FRA:6FV: 87.00
SoftOx Solutions AS (FRA:6FV) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
SoftOx Solutions AS EBIT per Share Related Terms
SoftOx Solutions AS EBIT per Share Historical Data
* Premium members only.
The historical data trend for SoftOx Solutions AS's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SoftOx Solutions AS (FRA:6FV) has a EBIT per Share of €0.00 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on SoftOx Solutions AS and its competitors. According to the industry distribution chart, SoftOx Solutions AS ranks #21 out of 1173 companies in the Biotechnology industry, placing it in the top 1.8%.
Is SoftOx Solutions AS's EBIT per Share too high?
SoftOx Solutions AS's current EBIT per Share is €0.00. Based on the distribution chart, SoftOx Solutions AS ranks #21 out of 1173 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, SoftOx Solutions AS has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does SoftOx Solutions AS's EBIT per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, SoftOx Solutions AS ranks #21 out of 1173 companies for EBIT per Share. This places SoftOx Solutions AS in the top 2% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 15.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.40, based on 1,173 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on SoftOx Solutions AS and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SoftOx Solutions AS's current EBIT per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SoftOx Solutions AS stock overvalued right now?
SoftOx Solutions AS (FRA:6FV) has a current EBIT per Share of €0.00. The current EBIT per Share is €0.00. SoftOx Solutions AS's overall GF Score™ is 27/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For SoftOx Solutions AS (FRA:6FV), the current EBIT per Share is €0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SoftOx Solutions AS is a clinical-stage pharmaceutical company. It offers antimicrobial solutions for Wound and Skin Care. It has developed an effective antimicrobial solution to combat biofilm, viral, and antimicrobial-resistant infections. The technology is based on extensive research and development in partnership with Nordic research institutes.
27GF Score
Get the complete analysis for FRA:6FV
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6FV has been successfully added to your 
